Will PAR’s H1 2020 financials trigger a surge this week?

In my opinion, biotechnology is the most entertaining industry in the stock market. Why? Three reasons.   1) Biotech tends to be up even when the market is down. Because our ageing population continues to demand the best medicine to sustain a higher life expectancy. 2) Second, there is a range of top-quality biotechs under […]

Will IMU’s cancer trials cause a surge in stock price?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Imugene Ltd (ASX:IMU) has one of the most exciting stock stories in the biotech industry. Why? Because IMU strives to cure cancer, through a range of new Immuno oncology therapies. […]

Does IMU’s 2020 cancer ‘cure’ clinical trials hold exponential stock growth?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Is there a cure for cancer? A question that instantly makes the scientific world wonder. However, creating a viable solution to cancer is difficult to prove. Because biotechnological and medical […]